Sun Pharma, Bharat Forge, Isgec Heavy in focus

9 Mar 2022 , 08:44 AM

Sun Pharmaceutical Industries: The companys subsidiary Taro Pharmaceuticals USA Inc has completed the acquisition of subsidiary companies of Galderma.

Bharat Forge: The auto ancillary company said its subsidiary Kalyani Strategic Systems (KSSL) has incorporated a company – Sagar-Manas Technologies (SMTL) on 7 March 2022 as a wholly owned subsidiary.

Isgec Heavy Engineering: Isgec has received an order from Shree Cement for Cement Waste Heat Recovery Boilers for their 3.8 MTPA clinker capacity, integrated Cement Plant at Nawalgarh, District Jhunjhunu, Rajasthan.

Zydus Lifesciences: Sentynl Therapeutics Inc., a wholly owned subsidiary of Zydus Lifesciences and BridgeBio Pharma announced asset purchase agreement for BridgeBio Pharmas NULIBRY (Fosdenopterin).

Yasho Industries: The company said the meeting of the board of directors of the company is scheduled on 16 March 2022 to consider and approve capital expenditure for a new greenfield project with a capacity of 15,500 metric tonne per annum at Bharuch, Gujarat.

Bafna Pharmaceuticals: Promoter SRJR Life Sciences LLP will sell 99,357 equity shares or 0.42% stake in the company through open market transactions. The purpose of this stake sale is to achieve minimum public shareholding.

Powered by Capital Market – Live News